Below you can search for drug products that are marketed for sale in Canada. The search results will show whether there has been a shortage and/or discontinuation report for the product.
To search for shortage and discontinuation reports, please refer to the Search Reports page.
For more information on how to search products, see “How to Search” section in the Website overview for public users, found in the About & Resources page.
| Brand name | Drug Identification Number | Company Name | Strength | Reports |
|---|---|---|---|---|
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 00786306 | BAXTER CORPORATION | 300MG, 900MG, 5G | 5 |
| TRAVASOL | 00388769 | BAXTER CORPORATION | 580MG, 480MG, 1.04G, 580MG, 2.08G, 2.08G, 620MG, 440MG, 460MG, 420MG, 180MG, 620MG, 40MG, 420MG | 0 |
| PERIOLIMEL 2.5% E | 02352494 | BAXTER CORPORATION | 0.42G, 1.99G, 1.0G, 0.06G, 0.30G, 82.50G, 1.16G, 1.76G, 1.51G, 3.66G, 2.48G, 0.45G, 6G, 1.76G, 1.26G, 1.26G, 1.76G, 1.19G, 24G, 1.26G, 1.26G, 1.51G, 1.91G, 1.62G, 0.73G | 0 |
| ACID CONCENTRATE D-18006 | 02158361 | BAXTER CORPORATION | 215G, 2.52G, 1.67G, 6.31G, 2.61G | 0 |
| OLIMEL 4.4% E | 02352516 | BAXTER CORPORATION | 3.48G, 0.74G, 2.21G, 2.21G, 3.07G, 0.81G, 1.50G, 2.64G, 0.52G, 2.21G, 154G, 3.67G, 3.07G, 1.28G, 4.34G, 3.07G, 6.41G, 1.75G, 32G, 2.21G, 8G, 0.11G, 2.24G, 2.83G, 2.64G | 1 |
| OLIMEL 4.4% | 02352524 | BAXTER CORPORATION | 3.07G, 1.75G, 2.21G, 4.34G, 3.07G, 3.48G, 6.41G, 1.28G, 154G, 0.74G, 2.64G, 3.07G, 8G, 2.21G, 2.83G, 2.21G, 32G, 0.11G, 2.21G, 2.64G | 0 |
| OLIMEL 5.7% E | 02352532 | BAXTER CORPORATION | 2.24G, 0.52G, 2.84G, 0.81G, 3.95G, 3.40G, 2.25G, 1.65G, 2.84G, 3.40G, 5.58G, 0.15G, 2.84G, 4.48G, 32G, 3.67G, 8.24G, 0.95G, 3.95G, 2.84G, 3.95G, 121G, 8G, 3.64G, 1.50G | 0 |
| ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP | 01960865 | BAXTER CORPORATION | 140MG, 1.66G, 2G, 17.3MG, 189MG | 0 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | 00438014 | BAXTER CORPORATION | 300MG, 150MG, 3.3G | 0 |
| (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP | 00438022 | BAXTER CORPORATION | 3.3G, 300MG, 300MG | 0 |
| ACID CONCENTRATE D12311 | 02250837 | BAXTER CORPORATION | 6.86G, 10.05G, 9.92G, 49.5G, 263G, 10.8G | 0 |
| MIDAZOLAM INJECTION, USP | 02529300 | BAXTER CORPORATION | 1MG | 0 |
| ACID CONCENTRATE D12311 | 02244100 | BAXTER CORPORATION | 263G, 10.05G, 6.86G, 9.92G, 49.5G | 0 |
| CLINIMIX | 02498464 | BAXTER CORPORATION | 32MG, 584MG, 824MG, 464MG, 336MG, 1656MG, 448MG, 480MG, 544MG, 14G, 320MG, 144MG, 384MG, 400MG, 920MG, 464MG | 0 |
| FUROSEMIDE INJECTION, USP | 02488868 | BAXTER CORPORATION | 10MG | 0 |
| VIVIA BICARB | 02388057 | BAXTER CORPORATION | 750G | 0 |
| MULTIPLE ELECTROLYTE ADDITIVE LIQ FORMULA 1 | 00809551 | BAXTER CORPORATION | 7.31G, 1.84G, 13.6G, 7.46G, 4.07G | 0 |
| ACID CONCENTRATE 2106 | 02239609 | BAXTER CORPORATION | 1.61G, 10.8G, 6.24G, 3.35G, 263G, 67.5G | 0 |
| CLINIMIX | 02498456 | BAXTER CORPORATION | 920MG, 480MG, 448MG, 32MG, 336MG, 464MG, 400MG, 824MG, 464MG, 584MG, 1656MG, 384MG, 320MG, 544MG, 144MG, 10G | 0 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 02488930 | BAXTER CORPORATION | 7.5MG | 1 |